Box–Behnken study design for optimization of bicalutamide-loaded nanostructured lipid carrier: stability assessment

References

• Mehnert W, Mäder K. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev 2001;47:165–196
   PubMed Web of Science ®Google Scholar
• Muller RH, Maassen S, Weyhers H, Mehnert W. Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407. J Drug Target 1996;4:161–170
   PubMed Web of Science ®Google Scholar
• Ravi Kumar MNV. Nano and microparticles as controlled drug delivery devices. J Pharm Pharmceut Sci 2000;3:234–258
   PubMed Web of Science ®Google Scholar
• Müller RH, Mäder K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art. Eur J Pharm Biopharm 2000;50:161–177
   PubMed Web of Science ®Google Scholar
• Rawat M, Singh D, Saraf S, Saraf S. Lipid carriers: a versatile delivery vehicle for proteins and peptides. Yakugaku Zasshi 2008;128:269–280
   PubMed Web of Science ®Google Scholar
• Peters K, Leitzke S, Diederichs JE, et al. Preparation of a clofazimine nanosuspension for intravenous use and evaluation of its therapeutic efficacy in murine Mycobacterium avium infection. J Antimicrob Chemother 2000;45:77–83
   PubMed Web of Science ®Google Scholar
• Radtke M, Souto EB, Müller RH. Nanostructured lipid carriers: a novel generation of solid lipid drug carriers. Pharm Tech Eur 2005;17:45–50
   Google Scholar
• Samad A, Sultana Y, Aqil M. Liposomal drug delivery systems: an update review. Curr Drug Deliv 2007;4:297–305
   PubMedGoogle Scholar
• Mozafari MR, Johnson C, Hatziantoniou S, Demetzos C. Nanoliposomes and their applications in food nanotechnology. J Lipo Res 2008;18:309–327
   Google Scholar
• Mu X, Zhong Z. Preparation and properties of poly (vinyl alcohol)-stabilized liposomes. Int J Pharm 2006;318:55–61
   PubMed Web of Science ®Google Scholar
• Mason TG, Wilking JN, Meleson K, et al. Nanoemulsions: formation, structure, and physical properties. J Phys Condensed Matter 2006;18:R635–R666
   Web of Science ®Google Scholar
• Sarker DK. Engineering of nanoemulsions for drug delivery. Curr Drug Deliv 2005;2:297–310
   PubMedGoogle Scholar
• Fathi M, Mozafari MR, Mohebbi M. Nanoencapsulation of food ingredients using lipid based delivery systems. Trends Food Sci Technol 2012;23:13–27
   Web of Science ®Google Scholar
• Klang V, Matsko NB, Valenta C, Hofer F. Electron microscopy of nanoemulsions: an essential tool for characterisation and stability assessment. Micron 2012;43:85–103
   PubMed Web of Science ®Google Scholar
• Gramdorf S, Hermann S, Hentschel A, et al. Crystallized miniemulsions: influence of operating parameters during high-pressure homogenization on size and shape of particles. Colloids Surf A Physicochem Eng Aspects 2008;331:108–113
   Google Scholar
• Müller RH, Mehnert W, Lucks JS, et al. Solid lipid nanoparticles (SLN): an alternative colloidal carrier system for controlled drug delivery. Eur J Pharm Biopharm 1995;41:62–69
   Web of Science ®Google Scholar
• Mäder K, Mehnert W. Solid lipid nanoparticles-concepts, procedures, and physicochemical aspects. In: Nastruzzi C, ed. Lipospheres in drug targets and delivery: approaches, methods, and applications. New York: CRC Press; 2005:1–22
   Google Scholar
• Mehnert W, Mäder K. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev 2012;64:83–101
   Web of Science ®Google Scholar
• Singhal GB, Patel RP, Prajapati BG, Patel NA. Solid lipid nanoparticles and nano lipid carriers: as novel solid lipid based drug carrier. Int Res J Pharm 2011;2:40–52
   Google Scholar
• Müller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 2002;54:S131–S155
   PubMed Web of Science ®Google Scholar
• Müller RH, Radtke M, Wissing SA. Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm 2002;242:121–128
   PubMed Web of Science ®Google Scholar
• Yuan H, Wang LL, Du YZ, et al. Preparation and characteristics of nanostructured lipid carriers for control-releasing progesterone by melt-emulsification. Colloids Surfs B Biointerfaces 2007;60:174–179
   PubMed Web of Science ®Google Scholar
• Varshosaz J, Hassanzadeh F, Sadeghi H, Khadem M. Galactosylated nanostructured lipid carriers for delivery of 5-FU to hepatocellular carcinoma. J Lipo Res 2012;22:224–236
   Google Scholar
• Khurana S, Utreja P, Tiwary AK, et al. Nanostructured lipid carriers and their application in drug delivery. Int J Biomed Eng Technol 2009;2:152–171
   Google Scholar
• Das S, Ng WK, Tan RBH. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? Eur J Pharm Sci 2012;47:139–151
   PubMed Web of Science ®Google Scholar
• Chen CC, Tsai TH, Huang ZR, Fang JY. Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics. Eur J Pharm Biopharm 2010;74:474–482
   PubMed Web of Science ®Google Scholar
• Singh AK, Chaurasiya A, Jain GK, et al. High performance liquid chromatography method for the pharmacokinetic study of bicalutamide SMEDDS and suspension formulations after oral administration to rats. Talanta 2009;78:1310–1314
   PubMed Web of Science ®Google Scholar
• Kolvenbag GJ, Nash A. Bicalutamide dosages used in the treatment of prostate cancer. Prostate 1999;39:47–53
   PubMedGoogle Scholar
• Ren F, Jing Q, Tang Y, et al. Characteristics of bicalutamide solid dispersions and improvement of the dissolution. Drug Dev Ind Pharm 2006;32:967–972
   PubMed Web of Science ®Google Scholar
• Rane SS, Anderson BD. What determines drug solubility in lipid vehicles: is it predictable? Adv Drug Deliv Rev 2008;60:638–656
   PubMed Web of Science ®Google Scholar
• Porter CJH, Pouton CW, Cuine JF, Charman WN. Enhancing intestinal drug solubilization using lipid-based delivery systems. Adv Drug Deliv Rev 2008;60: 673–691
   PubMed Web of Science ®Google Scholar
• Kumbhar DD, Pokharkar VB. Engineering of a nanostructured lipid carrier for the poorly water-soluble drug, bicalutamide: physicochemical investigations. Colloids Surf A Physicochem Eng Aspects 2013;416:32–42
   Web of Science ®Google Scholar
• Araújo J, Gonzalez-Mira E, Egea MA, et al. Optimization and physicochemical characterization of a triamcinolone acetonide-loaded NLC for ocular antiangiogenic applications. Int J Pharm 2010;393:167–175
   PubMed Web of Science ®Google Scholar
• Aslan N, Cebeci Y. Application of Box–Behnken design and response surface methodology for modeling of some Turkish coals. Fuel 2007;86:90–97
   Web of Science ®Google Scholar
• Box GEP, Behnken DW. Some new three level designs for the study of quantitative variables. Technometrics 1960;2:195 (1–11)
   Google Scholar
• Ferreira SLC, Bruns RE, Ferreira HS, et al. Box-Behnken design: an alternative for the optimization of analytical methods. Anal Chim Acta 2007;597:179–186
   PubMed Web of Science ®Google Scholar
• Hao J, Fang X, Zhou Y, et al. Development and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box-Behnken design. Int J Nanomed 2011;6:683–692
   PubMed Web of Science ®Google Scholar
• Amenaghawon NA, Nwaru KI, Aisien FA, et al. Application of Box-Behnken design for the optimization of citric acid production from corn starch using Aspergillus niger. Br Biotechnol J 2013;3:236–245
   Google Scholar
• Agrawal Y, Petkar KC, Sawant KK. Development, evaluation and clinical studies of Acitretin loaded nanostructured lipid carriers for topical treatment of psoriasis. Int J Pharm 2010;401:93–102
   PubMed Web of Science ®Google Scholar
• Chalikwar SS, Belgamwar VS, Talele VR, et al. Formulation and evaluation of Nimodipine-loaded solid lipid nanoparticles delivered via lymphatic transport system. Colloids Surf B Biointerfaces 2012;97:109–116
   PubMed Web of Science ®Google Scholar
• Sharma G, Modgil A, Layek B, et al. Cell penetrating peptide tethered bi-ligand liposomes for delivery to brain in vivo: biodistribution and transfection. J Control Release 2013;167:1–10
   PubMed Web of Science ®Google Scholar
• Wu L, Martin CG, Martyn CD, et al. Preparation of surface-modified albumin nanospheres. Biomaterials 1997;18:559–565
   PubMedGoogle Scholar
• Zhang J, Liang L, Tian Z, et al. Preparation and in vitro evaluation of calcium-induced soy protein isolate nanoparticles and their formation mechanism study. Food Chem 2012;133:390–399
   PubMed Web of Science ®Google Scholar
• Parveen S, Sahoo SK. Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery. Eur J Pharmacol 2011;670:372–383
   PubMed Web of Science ®Google Scholar
• Muppidi K, Pumerantz AS, Wang J, Betageri G. Development and stability studies of novel liposomal vancomycin formulations. ISRN Pharm 2012;2012:1–16
   Google Scholar
• Zhang X, Liu J, Qiao H, et al. Formulation optimization of dihydroartemisinin nanostructured lipid carrier using response surface methodology. Powder Technol 2010;197:120–128
   Web of Science ®Google Scholar
• Saez A, GuzmaÂn M, Molpeceres J, Aberturas MR. Freeze-drying of polycaprolactone and poly (d,l-lactic-glycolic) nanoparticles induce minor particle size changes affecting the oral pharmacokinetics of loaded drugs. Eur J Pharm Biopharm 2000;50:379–387
   PubMed Web of Science ®Google Scholar
• Montenegro L, Campisi A, Sarpietro MG, et al. In vitro evaluation of idebenone-loaded solid lipid nanoparticles for drug delivery to the brain. Drug Dev Ind Pharm 2011;37:737–746
   PubMed Web of Science ®Google Scholar
• Vivek K, Reddy H, Murthy R. Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles. AAPS PharmSciTech 2007;8:16–24
   PubMed Web of Science ®Google Scholar
• Sweet C, Zull JE. The binding of serum albumin to phospholipid liposomes. Biochim Biophys Acta 1970;219:253–262
   PubMedGoogle Scholar
• Shete H, Patravale V. Long chain lipid based tamoxifen NLC. Part I: Preformulation studies, formulation development and physicochemical characterization. Int J Pharm 2013;15:573–583
   Google Scholar